Compare Illumina, Inc. (ILMN) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Illumina, Inc. trades at $264.24 (market cap $40.43B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.47 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 8× Illumina, Inc.'s market cap, and Vanguard Tax Managed Fund FTSE Developed Markets ETF is more actively traded (9,762,021 versus 2,948,626). Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 131 Days on average.
| ILMN | VEA | |
|---|---|---|
Market Cap | $40.43B | $323.80B |
Volume | 2,948,626 | 9,762,021 |
Sector | Health | — |
52-Week High | $293.69 | $73.79 |
52-Week Low | $91.00 | $58.90 |
Typical Hold Time | 83 Days | 131 Days |
Enterprise Value | $41.79B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 3.34% on the day but up significantly year-to-date with strong technical momentum. The stock shows bullish moving average signals and trades near pivot point resistance at $268. Fundamentally, the company has delivered three consecutive quarterly earnings beats and returned to profitability in 2025 with $850 million net income after previous losses. Recent catalysts include S&P 500 inclusion effective September 21, 2026, and growing AI integration in genomics applications.
The outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI-driven biological data expansion, while risks involve China market headwinds and elevated valuation multiples. Earnings growth and S&P 500 inclusion provide near-term catalysts, but the stock trades at premium valuations with P/E of 49.96 requiring sustained execution.
VEA, the Vanguard FTSE Developed Markets ETF, trades at $70.26, down 1.2% on the day amid a bearish technical signal. The ETF provides cost-efficient exposure to developed markets outside the U.S., with a 0.03% expense ratio and competitive dividend yield. Recent news highlights institutional activity, with firms like Allianz Asset Management increasing stakes while others trimmed positions.
The outlook remains mixed, with technical indicators signaling caution but fundamental strengths in low costs and diversification. Key risks include global market volatility and currency fluctuations. Investors should weigh the ETF's stable, income-oriented profile against near-term bearish momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Vanguard Tax Managed Fund FTSE Developed Markets ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →
